Company Filing History:
Years Active: 2021
Title: Han Myint: Innovator in Cancer Treatment
Introduction
Han Myint is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of cancer treatment, particularly in the area of acute myeloid leukemia and multiple myeloma. His innovative approaches utilize natural killer cells to combat these challenging diseases.
Latest Patents
Han Myint holds a patent for "Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cells." This patent outlines methods for treating acute myeloid leukemia (AML) and multiple myeloma (MM) by administering an effective amount of a cell population comprising natural killer cells. The cell population is produced through a three-stage method that involves culturing hematopoietic stem or progenitor cells in media containing stem cell mobilizing factors. This innovative approach includes using cells from the placenta, umbilical cord blood, or peripheral blood to produce natural killer cells that can suppress the proliferation of AML cells.
Career Highlights
Han Myint is associated with Celularity Inc., a company focused on advancing cell-based therapies. His work has been instrumental in developing new treatment methodologies that leverage the body's immune system to fight cancer.
Collaborations
Some of his notable coworkers include Steven Alan Fischkoff and Uri Herzberg, who contribute to the innovative research environment at Celularity Inc.
Conclusion
Han Myint's work exemplifies the potential of innovative treatments in oncology, particularly through the use of natural killer cells. His contributions are paving the way for new therapeutic strategies in the fight against cancer.